Equibles does not estimate personal net worth.
Get an email with a short summary when Denali Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get DNLI alertsKatie Pang has spoken on 2 earnings calls across 1 company, most recently for Denali Therapeutics Inc. on November 3, 2026. Denali Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Denali Therapeutics Inc. includes Ryan J. Watts (CEO and Board Member), Alexander Schuth (CFO), Steve E. Krognes (CFO and Board Member) and 7 others.
“We are now two full quarters into the Ablea launch. Patient interest, physician engagement, and access are all moving faster than we expected. This has accelerated revenue growth.”
“On slide 12, I'd like to start by reinforcing why we believe Ablea is setting a new bar for the treatment of MPS2. For the first time, a therapy is designed to reach the whole body, including the brain, and can normalize key disease biomarkers, both in the CNS and peripherally.”
Transcript header (unverified)
Biotechnology · Healthcare
